CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale See Remarks sold 105,108 shares at $9.04 ($950,019)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 8-K Event Shareholder vote results
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
Page 1 of 28 · 558 filings